Elbit Medical Technologies Ltd

    Elbit Medical Technologies Ltd

    TTASE:EMTC-M
    - -
    ILA
    - -
    - -
    48.73P/E
    Elbit Medical Technologies Ltd
    TASE:EMTC-M
    (Tel Aviv Stock Exchange)

    Recent

    price

    - -

    P/E

    ratio

    48.73

    div

    yld

    - -

    ROIC.AI

    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    USD
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    0.17
    -0.05
    -0.04
    -0.07
    -0.08
    -0.05
    0.12
    -0.09
    0.99
    -0.17
    -0.06
    -0.2
    0.01
    0.01
    Basic EPS, GAAP
    -0.08
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -0.01
    -0.01
    -0.01
    -0.01
    -0.01
    -0.01
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    -0.49
    -0.52
    -0.59
    -0.67
    -0.72
    -0.6
    -0.69
    -0.3
    -0.59
    -0.64
    -0.83
    -0.82
    -0.42
    Book Value per Share
    - -
    0.03
    - -
    -0.06
    -0.14
    -0.18
    -0.07
    -0.16
    0.37
    0.34
    0.28
    0.08
    0.09
    0.4
    Tangible Book Value per Share
    225
    227
    231
    231
    231
    231
    231
    231
    124
    89
    91
    91
    91
    97
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    39
    -12
    -9
    -16
    -19
    -11
    27
    -21
    123
    -16
    -5
    -18
    1
    1
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    -1
    - -
    - -
    - -
    - -
    2
    1
    8
    3
    2
    1
    1
    7
    Working Capital
    - -
    31
    32
    34
    37
    42
    39
    47
    32
    - -
    - -
    - -
    - -
    - -
    LT Debt
    - -
    7
    1
    -13
    -32
    -42
    -15
    -37
    46
    31
    25
    7
    8
    39
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    -7.79
    - -
    -1.38
    - -
    - -
    - -
    -6.49
    -0.65
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    -28.05
    - -
    -213.52
    - -
    - -
    - -
    -1.1
    -40.87
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'20
    Mar'21
    Jun'21
    ST Debt
    - -
    31
    31
    LT Borrowings
    32
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    93
    93
    93
    Market Capitalization
    59
    46
    48

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'20
    Mar'21
    Jun'21
    Total Current Assets
    10
    43
    39
    Cash, Cash Equivalents & STI
    6
    4
    3
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    2
    32
    32
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    31
    31
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -153.81%
    -67.41%
    11.46%
    Free Cash Flow
    5.35%
    -0.12%
    -8.14%
    Net Income, GAAP
    -120.13%
    -143.21%
    -104.65%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    -0.2
    2024
    - -
    - -
    - -
    - -
    0.01
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business